PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Otorhinolaryngology10.21053/ceo.2020.022572021143347-354Type 2 Diabetes Mellitus Increases Peritonsillar Abscess Susceptibility: Real-World EvidenceChing-Lung Wu, Ming-Shao Tsai, Ta-Jen Lee, Yun-Ting Wang, Chia-Yen Liu, Yao-Hsu Yang, Yao-Te Tsai, Cheng-Ming Hsu, Ching-Yuan Wu, Pey-Jium Chang, Geng-He Changhttp://e-ceo.org/upload/pdf/ceo-2020-02257.pdf, http://e-ceo.org/journal/view.php?doi=10.21053/ceo.2020.02257, http://e-ceo.org/upload/pdf/ceo-2020-02257.pdf
Clinical Otolaryngology10.1111/j.1749-4486.2012.02452.x2012372136-145An evidence-based review of peritonsillar abscessJ. Powell, J.A. Wilsonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-4486.2012.02452.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-4486.2012.02452.x/fullpdf
Diabetes10.2337/db18-884-p201867Supplement_1A Real-World Evidence in Understanding the Barriers and Behaviours of Insulin Therapy among Indian Type 2 Diabetes Mellitus (T2DM) PatientsPRAVEEN RAJ, DILIP PAWAR, SARAH JABEEN, SHIVARAM VShttps://diabetesjournals.org/diabetes/article/67/Supplement_1/884-P/58702/A-Real-World-Evidence-in-Understanding-the, https://diabetesjournals.org/diabetes/article/67/Supplement_1/884-P/58702/A-Real-World-Evidence-in-Understanding-the
Diabetes Technology & Therapeutics10.1089/dia.2019.00522019218415-422Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT)Vijay Viswanathan, K.P. Singhhttps://www.liebertpub.com/doi/full-xml/10.1089/dia.2019.0052, https://www.liebertpub.com/doi/pdf/10.1089/dia.2019.0052
Value in Health10.1016/j.jval.2018.09.2310201821S389PRM192 - TYPE 2 DIABETES MELLITUS: LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.V. Lambert-Obry, J Lafrance, M Savoie, J Lachainehttps://api.elsevier.com/content/article/PII:S1098301518356122?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301518356122?httpAccept=text/plain
Diabetes mellitus10.14341/dm12803202225161-71Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian FederationO. K. Vikulova, G. R. Galstyan, M. V. Shestakovahttps://www.dia-endojournals.ru/jour/article/viewFile/12803/pdf_100
Diabetes10.2337/db20-608-p202069Supplement_1608-P: Empagliflozin Ameliorates Ankle-Brachial Index in Real-World Setting in Indian Patients with Type 2 Diabetes MellitusDAKSHATA PADHYEhttps://diabetesjournals.org/diabetes/article/69/Supplement_1/608-P/57139/608-P-Empagliflozin-Ameliorates-Ankle-Brachial, https://diabetesjournals.org/diabetes/article/69/Supplement_1/608-P/57139/608-P-Empagliflozin-Ameliorates-Ankle-Brachial
Diabetes mellitus10.14341/2072-0351-5630201114223-31The role of common genetic markers in susceptibility to type 1 diabetes and autoimmune thyroid diseasesEkaterina Alexandrovna Repinahttps://dia-endojournals.ru/dia/article/viewFile/5630/3408, https://dia-endojournals.ru/dia/article/viewFile/5630/3408
Type 2 Diabetes Mellitus10.1007/978-1-60327-043-4_102008151-167Type 2 Diabetes Mellitus: An Evidence-Based Approach to Practical ManagementIldiko Lingvay, Chanhaeng Rhee, Philip Raskinhttp://link.springer.com/content/pdf/10.1007/978-1-60327-043-4_10
Diabetes10.2337/db18-2382-pub201867Supplement_1The TenYear, Real-World Population-Based Study in Diabetes Nephropathy with Microproteinuria in Type 2 Diabetes Mellitus—Based on the Diabetes Case Management Program 2001, TaiwanMARTIN M.T. FUH, PEI CHIN CHENhttps://diabetesjournals.org/diabetes/article/67/Supplement_1/2382-PUB/57190/The-TenYear-Real-World-Population-Based-Study-in, https://diabetesjournals.org/diabetes/article/67/Supplement_1/2382-PUB/57190/The-TenYear-Real-World-Population-Based-Study-in